Ativan

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0641-6002
  • Package NDC 0641-6002-10
  • Application number NDA018140
  • SPL ID fb40dcce-9da3-49b4-9bde-e01a17abeae6
  • SPL set ID 5fc0e987-61c9-40c4-b0d5-fcea07c8733e
  • UNII O26FZP769L
  • RxCUI 206819
  • RxCUI 206820
  • RxCUI 238100
  • RxCUI 238101
  • RxCUI 1665188
  • RxCUI 1665190
  • RxCUI 1665326
  • RxCUI 1665327

What the source publishes

Labeler
Hikma Pharmaceuticals USA Inc.
Active ingredients
Lorazepam
Form
INJECTION
Routes
INTRAMUSCULAR, INTRAVENOUS
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0641-6002_fb40dcce-9da3-49b4-9bde-e01a17abeae6
{
  "name": "Ativan",
  "splId": "fb40dcce-9da3-49b4-9bde-e01a17abeae6",
  "labels": [
    {
      "setId": "5fc0e987-61c9-40c4-b0d5-fcea07c8733e",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5fc0e987-61c9-40c4-b0d5-fcea07c8733e",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=5fc0e987-61c9-40c4-b0d5-fcea07c8733e"
    }
  ],
  "routes": [
    "INTRAMUSCULAR",
    "INTRAVENOUS"
  ],
  "labeler": "Hikma Pharmaceuticals USA Inc.",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "10 VIAL in 1 CARTON (0641-6002-10)  / 10 mL in 1 VIAL (0641-6002-01)",
      "package_ndc": "0641-6002-10",
      "identifierStatus": "well-formed",
      "marketing_start_date": "19800725"
    }
  ],
  "productId": "0641-6002_fb40dcce-9da3-49b4-9bde-e01a17abeae6",
  "useDomain": "unknown",
  "dosageForm": "INJECTION",
  "productNdc": "0641-6002",
  "deaSchedule": "CIV",
  "genericName": "Lorazepam",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "LORAZEPAM",
      "strength": "4 mg/mL"
    }
  ],
  "applicationNumber": "NDA018140",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "19800725",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000175694",
      "M0002356"
    ],
    "unii": [
      "O26FZP769L"
    ],
    "rxcui": [
      "206819",
      "206820",
      "238100",
      "238101",
      "1665188",
      "1665190",
      "1665326",
      "1665327"
    ],
    "spl_set_id": [
      "5fc0e987-61c9-40c4-b0d5-fcea07c8733e"
    ],
    "pharm_class_cs": [
      "Benzodiazepines [CS]"
    ],
    "pharm_class_epc": [
      "Benzodiazepine [EPC]"
    ],
    "manufacturer_name": [
      "Hikma Pharmaceuticals USA Inc."
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0641-6002_fb40dcce-9da3-49b4-9bde-e01a17abeae6"